13F HOLDINGS REPORT
Catalys Pacific, LLC
Quarter ended Q3 2024 · Filed November 12, 2024 · Accession 0001104659-24-116643
Total Value
$125.4M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 8,644,579 | $104.7M | 83.48% |
| 2 | Phathom Pharmaceuticals, Inc. | PHAT | 1,122,572 | $20.3M | 16.19% |
| 3 | HilleVax, Inc. | 43157M102 | 236,379 | $416,027 | 0.33% |